Abstract

Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2021 - Volume 25, Number 4

Page(s): 327

Download in electronic PDF format for $75
  • Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored Page 1

Abstract

A formulation for preparing Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • nifedipine
  • oral suspension
  • Prinzmetal variant angina
  • chronic stable angina pectoris
  • chest pain
  • hypertension
  • high blood pressure
  • Raynaud phenomenon
  • preterm labor
  • acute myocardial infarction
  • heart attack
  • cardiac disorders
  • heart disease

Related Categories

  • FORMULATIONS
  • CARDIOLOGY
  • DOSAGE FORMS/DRUG CARRIERS
  • ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2021
Pg. 327
Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored
Author(s): Allen Loyd V Jr
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2021
Pg. 503
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2018
Pg. 233
Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Mar/Apr 2022
Pg. 146
Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored
Author(s): Allen Loyd V Jr
Mar/Apr 2019
Pg. 147
Amlodipine 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2003
Pg. 48-50
Featured Excipient: Flavor Enhancing Agents
Author(s): Allen Loyd V Jr
Sep/Oct 2011
Pg. 423
Nifedipine 10-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 54
Amiodarone Hydrochloride 5 mg/mL in SyrSpend SF pH4 Cherry Flavored
Author(s): Allen Loyd V Jr
Nov/Dec 2018
Pg. 493
Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2006
Pg. 303
Nifedipine 4-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Sep/Oct 2011
Pg. 422
Nifedipine 1-mg/500-mg Oral Powder
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 487
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 421
Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Jul/Aug 2022
Pg. 270-274
A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline
Author(s): Riepl Mike
Jan/Feb 2023
Pg. 12-21
Compounding for the Treatment of COVID-19 and Long COVID, Part 1: Terminology, Mutations, and Variants
Author(s): Riepl Mike
Nov/Dec 2018
Pg. 494
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 494
Verapmail Hydrochloride 50 mg/mL in SyrSpend SF
Author(s): Allen Loyd V Jr